论文部分内容阅读
[目的]根据2009年全国各肿瘤登记处恶性肿瘤登记数据资料,分析我国肿瘤登记地区肾癌的发病与死亡情况。[方法]以入选的72个肿瘤登记处的数据为依据,采用一般性描述方法分析肾癌的发病和死亡流行情况。[结果]2009年全国肾癌新发病例4916例,死亡1619例。M/I为0.33,MV%为76.61%,DCO%为1.22%,UB%为0.69%。登记地区肾癌发病率为5.75/10万(男性7.07/10万,女性4.40/10万),中标率为3.03/10万,世标率为3.95/10万,累积率(0～74岁)为0.45%;死亡率为1.89/10万(男性2.37/10万,女性1.41/10万),中标率为0.88/10万,世标率为1.21/10万,累积率(0～74岁)为0.12%。[结论]我国肾癌的发病率和死亡率城市明显高于农村,男性高于女性。在不同地区、不同性别中,随年龄的增长肾癌发病率和死亡率均呈上升趋势。
[Objective] To analyze the incidence and mortality of renal cell carcinoma in China’s cancer registration areas according to the data of malignant tumors registered in 2009 in China. [Method] Based on the data of 72 selected cancer registries, a general description method was used to analyze the incidence and death of renal cell carcinoma. [Results] In 2009, 4916 new cases of renal cell carcinoma were found in China, with 1619 deaths. M / I was 0.33, MV% was 76.61%, DCO% was 1.22% and UB% was 0.69%. The incidence of renal cell carcinoma was 5.75 / 100,000 (7.07 / 100,000 in males and 4.40 / 100 in females) in registered areas. The successful rate was 3.03 / 100,000 and the world standard rate was 3.95 / 100,000. The accumulative rate (0-74 years) The death rate was 1.89 / 100,000 (male 2.37 / 100000, female 1.41 / 100000), the winning rate was 0.88 / 100000, the world standard rate was 1.21 / 100000, the cumulative rate (0-74 years) 0.12%. [Conclusion] The incidence of morbidity and mortality of renal cancer in our country is obviously higher than that in rural areas, and the male is higher than the female. In different regions and different genders, with the increase of age, the incidence of renal cell carcinoma and mortality are on the rise.